Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2021 | 2 |
2023 | 3 |
2024 | 1 |
Search Results
4 results
Results by year
Filters applied: . Clear all
Page 1
Outcomes of COVID-19 in patients with lymphomas participating in registered clinical trials: A real-world study from China in the Omicron outbreak era.
Cancer Med. 2023 Dec;12(23):21148-21158. doi: 10.1002/cam4.6678. Epub 2023 Nov 27.
Cancer Med. 2023.
PMID: 38011015
Free PMC article.
Tislelizumab monotherapy in patients with previously untreated early-stage classical Hodgkin lymphoma: a real-world study.
Sun P, Yang H, Wang Y, Zhao B, Nie M, Huang K, Li Z.
Sun P, et al.
Ann Hematol. 2024 Mar;103(3):793-801. doi: 10.1007/s00277-023-05541-7. Epub 2023 Nov 13.
Ann Hematol. 2024.
PMID: 37953379
Item in Clipboard
Review on natural killer/T-cell lymphoma.
He X, Gao Y, Li Z, Huang H.
He X, et al.
Hematol Oncol. 2023 Apr;41(2):221-229. doi: 10.1002/hon.2944. Epub 2021 Dec 9.
Hematol Oncol. 2023.
PMID: 34731509
Review.
Item in Clipboard
Combined tumor-associated macrophages biomarker predicting extremely poor outcome of patients with primary central nervous system lymphoma.
Sun X, Wang C, Chen C, Huang J, Wu X, Wang Y, He X, Cao J, Jiang W, Sun P, Li Z.
Sun X, et al.
Hematol Oncol. 2021 Dec;39(5):625-638. doi: 10.1002/hon.2926. Epub 2021 Sep 20.
Hematol Oncol. 2021.
PMID: 34543472
Item in Clipboard
Cite
Cite